Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
November 02, 2023 08:00 ET
|
Ractigen Therapeutics
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer
July 13, 2023 04:00 ET
|
SiSaf Ltd
GUILDFORD, England, July 13, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I....
SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
April 05, 2023 03:00 ET
|
SiSaf Ltd
GUILDFORD, England, April 05, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd today announced that it has appointed Dr. Richard Goodfellow to its Board of Directors. ...
Advancements in miRNA Report 2022: Development of POC Diagnostics to Detect Circulating Biomarkers Across Diseases
October 10, 2022 08:03 ET
|
Research and Markets
Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Advancements in miRNA: Technology Assessment" report has been added to ResearchAndMarkets.com's offering. Accelerated research around RNA-based...
Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech, Editas Medicine and Intellia Therapeutics
April 19, 2022 04:08 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering....
Global RNAi Therapeutics Market Report 2022-2026: Analysis by Molecule Type - Small Interference RNA (siRNA), and Micro RNA (miRNA)
April 08, 2022 06:23 ET
|
Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026"...
PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation
February 10, 2021 02:31 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 10 February 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today released...
PCI Biotech to present at RNA Therapeutics Virtual Conference
January 22, 2021 06:04 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 22 January 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...